Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,618
datasets available to search
ShareScore release 0.9.0
Dataset results
1,618 results for “gemcitabine”
First Line Gemcitabine, Cisplatin and MEK162 in Advanced Biliary Tract Carcinoma
ClinicalTrials.gov study NCT01828034. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Low Dose Upper Abdominal Radiation Therapy (LD-UART) + Gemcitabine in Patients With Advanced, Unresectable Pancreatic Cancer (PC)
ClinicalTrials.gov study NCT00390182. IPD Sharing: Not stated. Countries: 2. Publications: 0.
A Study of First Line Treatment With Tarceva (Erlotinib) in Combination With Gemcitabine in Patients With Unresectable Advanced and/or Metastatic Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT00701558. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Bevacizumab or Cetuximab And Gemcitabine Hydrochloride, Capecitabine, and Radiation Therapy in Treating Patients With Pacreatic Cancer That Has Been Completely Removed By Surgery
ClinicalTrials.gov study NCT00305877. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ZN-c3 + Gemcitabine in Pancreatic Cancer
ClinicalTrials.gov study NCT06015659. IPD Sharing: YES. Countries: 1. Publications: 0.
Cetuximab, Gemcitabine, and Oxaliplatin Followed By Surgery or External-Beam Radiation Therapy and Capecitabine in Treating Patients With Locally Advanced, Nonmetastatic Pancreatic Cancer That Cannot
ClinicalTrials.gov study NCT00408564. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Pilot, Neoadjuvant Gemcitabine and Abraxane Chemotherapy Followed by Surgery, Adenocarcinoma of the Pancreas
ClinicalTrials.gov study NCT01783054. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Gemcitabine With or Without Combination Chemotherapy and Radiation Therapy in Treating Patients With Nonmetastatic Pancreatic Cancer That Cannot Be Removed By Surgery
ClinicalTrials.gov study NCT00416507. IPD Sharing: Not stated. Countries: 0. Publications: 1.
Avelumab in Combination With Gemcitabine in Advanced Leiomyosarcoma as a Second-line Treatment
ClinicalTrials.gov study NCT03536780. IPD Sharing: NO. Countries: 1. Publications: 11.
Gemcitabine and Split-dose Cisplatin (GC) Plus Sorafenib in Chemotherapy-naïve Patients With Locally Advanced or Metastatic Urothelial Carcinoma
ClinicalTrials.gov study NCT00714948. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Gemcitabine and S-1 for Locally Advanced Unresectable or Metastatic Pancreatic Cancer
ClinicalTrials.gov study NCT00429858. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of Avastin (Bevacizumab) in Combination With Gemcitabine With or Without Cisplatin in First-Line Treatment of Elderly Patients With Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT01077713. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Randomized Phase 2 Study With Gemcitabine Alone and Combination Therapy for Patients With Advanced Biliary Tract Cancer
ClinicalTrials.gov study NCT00380588. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Gemcitabine and Pemetrexed Disodium in Treating Patients With Advanced Mycosis Fungoides or Sézary Syndrome
ClinicalTrials.gov study NCT00369629. IPD Sharing: Not stated. Countries: 1. Publications: 0.
S0353, Gemcitabine in Treating Patients With Recurrent Bladder Cancer That Has Not Responded to Previous Bacillus Calmette-Guerin
ClinicalTrials.gov study NCT00234039. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Pemetrexed-Carboplatin and Gemcitabine-Vinorelbine in Advanced Breast Cancer
ClinicalTrials.gov study NCT00325234. IPD Sharing: Not stated. Countries: 5. Publications: 0.
Study of Vorinostat in Combination With Gemcitabine and Docetaxel in Advanced Sarcoma
ClinicalTrials.gov study NCT01879085. IPD Sharing: NO. Countries: 1. Publications: 0.
Gemcitabine Combinations in Metastatic Breast Cancer (MBC), 1st Line
ClinicalTrials.gov study NCT00191854. IPD Sharing: Not stated. Countries: 6. Publications: 0.
Testing the Addition of an Anti-cancer Immune Therapy Drug (Nivolumab) to the Usual Chemotherapy Treatment (Cisplatin or Carboplatin With Gemcitabine) for Recurrent or Metastatic Nasopharyngeal Cancer
ClinicalTrials.gov study NCT04458909. IPD Sharing: YES. Countries: 4. Publications: 0.
S0312, Gemcitabine and Capecitabine in Treating Patients With Advanced Renal Cell (Kidney) Cancer
ClinicalTrials.gov study NCT00058318. IPD Sharing: Not stated. Countries: 0. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.